lansoprazole has been researched along with Ischemia in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury." | 7.72 | Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004) |
| "Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury." | 3.72 | Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, H | 1 |
| Yoshida, N | 1 |
| Takagi, T | 1 |
| Tomatsuri, N | 1 |
| Katada, K | 1 |
| Isozaki, Y | 1 |
| Uchiyama, K | 1 |
| Naito, Y | 1 |
| Okanoue, T | 1 |
| Yoshikawa, T | 1 |
| Schönhöfer, PS | 1 |
2 other studies available for lansoprazole and Ischemia
| Article | Year |
|---|---|
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Gastrointestinal Agents; Inflammation; Intestinal | 2004 |
Safety of omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Humans; Ischemia; Lansoprazole; Male; Mi | 1994 |